Alembic Limited (ALEMBICLTD.NS)
INR 145.5
(1.35%)
INR 145.5
(1.35%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 1 Billion INR | -9.82% |
| 2022 | 861.2 Million INR | 113.69% |
| 2021 | 403.01 Million INR | 2.62% |
| 2020 | 392.73 Million INR | 37.05% |
| 2019 | 286.57 Million INR | -29.21% |
| 2018 | 404.79 Million INR | 20.58% |
| 2017 | 335.7 Million INR | -5.29% |
| 2016 | 354.46 Million INR | -37.04% |
| 2015 | 562.98 Million INR | -17.87% |
| 2014 | 685.51 Million INR | -26.54% |
| 2013 | 933.18 Million INR | 19.78% |
| 2012 | 779.09 Million INR | -88.7% |
| 2011 | 6.89 Billion INR | 1630.05% |
| 2010 | 398.38 Million INR | -96.49% |
| 2009 | 11.35 Billion INR | 101.09% |
| 2008 | 5.64 Billion INR | -45.97% |
| 2007 | 10.45 Billion INR | 49.03% |
| 2006 | 7.01 Billion INR | 6.33% |
| 2005 | 6.59 Billion INR | 22.53% |
| 2004 | 5.38 Billion INR | -2.89% |
| 2003 | 5.54 Billion INR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 244.7 Million INR | -18.6% |
| 2023 Q1 | 238 Million INR | -7.36% |
| 2023 FY | 776.6 Million INR | -9.82% |
| 2023 Q2 | 224.4 Million INR | -5.71% |
| 2023 Q3 | 251.9 Million INR | 12.25% |
| 2023 Q4 | 300.6 Million INR | 19.33% |
| 2022 Q4 | 256.9 Million INR | 20.38% |
| 2022 Q1 | 155.4 Million INR | 1296.4% |
| 2022 Q2 | 235.2 Million INR | 51.35% |
| 2022 Q3 | 213.4 Million INR | -9.27% |
| 2022 FY | 861.2 Million INR | 113.69% |
| 2021 FY | 403.01 Million INR | 2.62% |
| 2021 Q4 | -12.98 Million INR | -109.62% |
| 2021 Q3 | 135 Million INR | -7.79% |
| 2021 Q2 | 146.4 Million INR | 12.96% |
| 2021 Q1 | 129.6 Million INR | 202.56% |
| 2020 Q2 | 120.1 Million INR | 18.44% |
| 2020 Q3 | 128.4 Million INR | 6.91% |
| 2020 FY | 392.73 Million INR | 37.05% |
| 2020 Q4 | 42.83 Million INR | -66.64% |
| 2020 Q1 | 101.4 Million INR | 386.2% |
| 2019 Q3 | 91.9 Million INR | -20.5% |
| 2019 Q2 | 115.6 Million INR | 0.96% |
| 2019 Q4 | -35.43 Million INR | -138.55% |
| 2019 FY | 286.57 Million INR | -29.21% |
| 2019 Q1 | 114.5 Million INR | 306.66% |
| 2018 Q3 | 114.3 Million INR | -34.54% |
| 2018 Q2 | 174.6 Million INR | 1.93% |
| 2018 Q1 | 171.3 Million INR | 34.04% |
| 2018 FY | 404.79 Million INR | 20.58% |
| 2018 Q4 | -55.4 Million INR | -148.47% |
| 2017 FY | 335.7 Million INR | -5.29% |
| 2017 Q4 | 127.8 Million INR | 0.0% |
| 2016 Q4 | 141.3 Million INR | 0.0% |
| 2016 FY | 354.46 Million INR | -37.04% |
| 2015 Q3 | 73.8 Million INR | -61.72% |
| 2015 Q2 | 192.8 Million INR | -29.53% |
| 2015 Q1 | 273.6 Million INR | 61.31% |
| 2015 FY | 562.98 Million INR | -17.87% |
| 2015 Q4 | 105.1 Million INR | 42.41% |
| 2014 FY | 685.51 Million INR | -26.54% |
| 2014 Q2 | 324.4 Million INR | 79.13% |
| 2014 Q3 | 152.1 Million INR | -53.11% |
| 2014 Q4 | 169.61 Million INR | 11.51% |
| 2014 Q1 | 181.1 Million INR | -10.21% |
| 2013 Q1 | 197.3 Million INR | -14.14% |
| 2013 Q4 | 201.68 Million INR | -12.84% |
| 2013 Q3 | 231.4 Million INR | -18.46% |
| 2013 Q2 | 283.8 Million INR | 43.84% |
| 2013 FY | 933.18 Million INR | 19.78% |
| 2012 Q3 | 317.2 Million INR | 138.5% |
| 2012 Q4 | 229.79 Million INR | -27.55% |
| 2012 FY | 779.09 Million INR | -88.7% |
| 2012 Q1 | 116.4 Million INR | -98.19% |
| 2012 Q2 | 133 Million INR | 14.26% |
| 2011 Q3 | 150.1 Million INR | 0.0% |
| 2011 FY | 6.89 Billion INR | 1630.05% |
| 2011 Q4 | 6.41 Billion INR | 4173.88% |
| 2010 FY | 398.38 Million INR | -96.49% |
| 2009 FY | 11.35 Billion INR | 101.09% |
| 2008 Q4 | 1.3 Billion INR | 0.0% |
| 2008 FY | 5.64 Billion INR | -45.97% |
| 2007 FY | 10.45 Billion INR | 49.03% |
| 2006 FY | 7.01 Billion INR | 6.33% |
| 2005 FY | 6.59 Billion INR | 22.53% |
| 2004 FY | 5.38 Billion INR | -2.89% |
| 2003 FY | 5.54 Billion INR | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Sigachi Industries Limited | 2 Billion INR | 50.052% |
| Ind-Swift Limited | 2.17 Billion INR | 53.966% |
| Bajaj HealthCare Limited | 1.47 Billion INR | 32.049% |
| Sakar Healthcare Limited | 699.58 Million INR | -42.957% |
| Aurobindo Pharma Limited | 109.54 Billion INR | 99.087% |
| Innova Captab Limited | 3.46 Billion INR | 71.132% |
| Divi's Laboratories Limited | 32.44 Billion INR | 96.917% |
| AstraZeneca Pharma India Limited | 6.22 Billion INR | 83.928% |
| Morepen Laboratories Limited | 6.16 Billion INR | 83.768% |
| Mankind Pharma Limited | 42.19 Billion INR | 97.63% |
| Sequent Scientific Limited | 2.97 Billion INR | 66.425% |
| Wanbury Limited | 1.73 Billion INR | 42.212% |
| Laurus Labs Limited | 15.44 Billion INR | 93.526% |
| Nectar Lifesciences Limited | 4.82 Billion INR | 79.265% |
| Glenmark Life Sciences Limited | 12.43 Billion INR | 91.956% |
| Hikal Limited | 5.95 Billion INR | 83.214% |
| Alembic Pharmaceuticals Limited | 26.78 Billion INR | 96.266% |
| Neuland Laboratories Limited | 8.24 Billion INR | 87.874% |
| J. B. Chemicals & Pharmaceuticals Limited | 15.25 Billion INR | 93.446% |
| Glenmark Pharmaceuticals Limited | 69.34 Billion INR | 98.558% |
| IOL Chemicals and Pharmaceuticals Limited | 4.71 Billion INR | 78.807% |
| Themis Medicare Limited | 2.42 Billion INR | 58.673% |
| RPG Life Sciences Limited | 2.48 Billion INR | 59.722% |
| Zydus Lifesciences Limited | 125.21 Billion INR | 99.201% |
| Lupin Limited | 125.09 Billion INR | 99.201% |
| Amrutanjan Health Care Limited | 2.09 Billion INR | 52.24% |
| Wockhardt Limited | 7.72 Billion INR | 87.045% |
| Vaishali Pharma Limited | 90.32 Million INR | -1007.256% |
| Aarti Pharmalabs Limited | 5.83 Billion INR | 82.849% |
| Jagsonpal Pharmaceuticals Limited | 652.59 Million INR | -53.252% |
| Jubilant Pharmova Limited | 19.64 Billion INR | 94.909% |
| FDC Limited | 6.58 Billion INR | 84.815% |
| Dr. Reddy's Laboratories Limited | 163.6 Billion INR | 99.389% |
| Kilitch Drugs (India) Limited | 620.47 Million INR | -61.184% |
| Eris Lifesciences Limited | 10.42 Billion INR | 90.408% |
| Venus Remedies Limited | 2.18 Billion INR | 54.178% |
| ZIM Laboratories Limited | 1.26 Billion INR | 21.116% |
| Bliss GVS Pharma Limited | 3.69 Billion INR | 72.937% |
| Par Drugs and Chemicals Limited | 529.13 Million INR | -89.008% |
| Caplin Point Laboratories Limited | 9.2 Billion INR | 89.137% |
| Shilpa Medicare Limited | 3.56 Billion INR | 71.922% |
| Albert David Limited | 1.4 Billion INR | 28.974% |
| Ajanta Pharma Limited | 21.06 Billion INR | 95.252% |
| Hester Biosciences Limited | 1.27 Billion INR | 21.477% |
| Suven Pharmaceuticals Limited | 4.12 Billion INR | 75.745% |
| Solara Active Pharma Sciences Limited | -1.65 Billion INR | 160.397% |
| Gufic Biosciences Limited | 4.07 Billion INR | 75.45% |
| Windlas Biotech Limited | 1.33 Billion INR | 25.298% |
| Procter & Gamble Health Limited | 5.78 Billion INR | 82.701% |
| Aarey Drugs & Pharmaceuticals Limited | 113.02 Million INR | -784.823% |
| Mangalam Drugs & Organics Limited | 691.19 Million INR | -44.693% |
| Granules India Limited | 16.79 Billion INR | 94.047% |
| Aarti Drugs Limited | 8.31 Billion INR | 87.974% |
| Bal Pharma Limited | 770.19 Million INR | -29.851% |
| Alkem Laboratories Limited | 52.29 Billion INR | 98.088% |
| Sun Pharmaceutical Industries Limited | 258.48 Billion INR | 99.613% |
| Lincoln Pharmaceuticals Limited | 1.88 Billion INR | 46.996% |
| Medicamen Biotech Limited | 495.49 Million INR | -101.84% |
| Unichem Laboratories Limited | 4.86 Billion INR | 79.443% |
| Bafna Pharmaceuticals Limited | 452.15 Million INR | -121.188% |
| Biofil Chemicals and Pharmaceuticals Limited | 12.54 Million INR | -7872.156% |
| Valiant Laboratories Limited | 138.02 Million INR | -624.563% |
| Orchid Pharma Limited | 2.32 Billion INR | 56.898% |
| Medico Remedies Limited | 262.14 Million INR | -281.511% |
| Ind-Swift Laboratories Limited | 4.13 Billion INR | 75.803% |
| Ipca Laboratories Limited | 48.58 Billion INR | 97.941% |
| Brooks Laboratories Limited | 65.62 Million INR | -1424.089% |
| Syncom Formulations (India) Limited | 559.5 Million INR | -78.749% |
| Piramal Enterprises Limited | 8.04 Billion INR | 87.566% |
| Torrent Pharmaceuticals Limited | 46.75 Billion INR | 97.861% |
| NATCO Pharma Limited | 25.73 Billion INR | 96.114% |
| Suven Life Sciences Limited | -200.79 Million INR | 598.069% |
| Krebs Biochemicals & Industries Limited | -108.74 Million INR | 1019.664% |
| Strides Pharma Science Limited | 14.38 Billion INR | 93.049% |
| Indoco Remedies Limited | 8.04 Billion INR | 87.565% |
| Alpa Laboratories Limited | 188.89 Million INR | -429.451% |
| Lasa Supergenerics Limited | 121.02 Million INR | -726.33% |
| Sun Pharma Advanced Research Company Limited | 391.06 Million INR | -155.739% |